XFOR US EQUITY Health Care Health Care CIK: 1501697

X4 Pharmaceuticals, Inc (XFOR) Quant Factor Diagnostic & Fair Value Model

X4 Pharmaceuticals, Inc (Ticker: XFOR) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$3.24

+1.25% Latest Close (2026-10-23)

Market Cap: $321.24M

P/E Ratio: 2.3

Momentum Strength 3M / 12M

-17.77%

1M: +8.00% 12M: 0.00%

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

60.1

SMA50: $3.41 SMA200: $3.72

Valuation Multiplier Trailing

2.3

Deep Value (Under 15x P/E)

📊 Valuation & Multi-Factor Diagnostic

Deep Value (Under 15x P/E)

XFOR trades at an attractive earnings multiple of 2.3x, significantly lower than the broader S&P 500 average.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 4/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1501697 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1501697

💡 Methodology & Frequently Asked Questions

Key reference details regarding X4 Pharmaceuticals, Inc (XFOR) valuation multiples, momentum factors, and point-in-time filing conventions.

How should XFOR's current valuation multiple be interpreted? ↓

XFOR trades at a trailing P/E of 2.3x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are XFOR's key momentum and technical factor indicators? ↓

As of the latest close, XFOR shows a 1-month return of +8.00%, 3-month return of -17.77%, and 12-month return of 0.00%, with a 14-day RSI of 60.1. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for XFOR? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can XFOR be incorporated into systematic factor models? ↓

XFOR can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.